Home LiteratureArticle Details
PMID: 6784571 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

An analysis of error rates for disc agar-diffusion testing of Pseudomonas aeruginosa versus aminoglycosides.

American journal of clinical pathology ·Vol. 75 ·No. 4 ·1981-04-00 ·Pages 559-64

Woolfrey BF, Fox JM, Quall CO

Abstract

Five hundred thirty-five recent clinical isolates of Pseudomonas aeruginosa were tested in parallel by the standardized disc agar-diffusion test and a micro-broth dilution test to evaluate the error rates associated with the use of both fixed indeterminate-zone breakpoints and floating indeterminate-zone breakpoints for assessing susceptibility to amikacin, gentamicin, and tobramycin. Error rate-bound analysis showed that unacceptably high rates of error were associated with the use of all fixed breakpoints. Error rates were improved when the floating indeterminate-zone principle was used, but rates still remained unacceptably high. These findings indicate the disc agar-diffusion test should not be used for testing the susceptibility of P. aeruginosa to the aminoglycosides.

MeSH Terms
Amikacin/pharmacology Aminoglycosides/pharmacology False Negative Reactions False Positive Reactions Gentamicins/pharmacology Microbial Sensitivity Tests/methods Pseudomonas aeruginosa/drug effects Tobramycin/pharmacology
Chemicals
Aminoglycosides Gentamicins Amikacin Tobramycin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Woolfrey B F
Fox J M
Quall C O
Article Info
Journal
American journal of clinical pathology
Abbr.
Am J Clin Pathol
ISSN
0002-9173
Published
1981-04-00
Pages
559-64
Language
English
Region
England
NLM ID
0370470
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]